PITAVASTATIN CALCIUM

PITAVASTATIN CALCIUM was reported 10341 times

PITAVASTATIN CALCIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 229 0.2126
1 VISCERAL PAIN 6 0.0652
2 URINARY TRACT DISORDER 199 0.0441
3 PROTHROMBIN TIME RATIO INCREASED 7 0.0323
4 HAEMORRHAGIC STROKE 252 0.0322
5 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 6 0.0258
6 INFECTIVE SPONDYLITIS 6 0.0249
7 OCULAR DISCOMFORT 238 0.0212
8 MERYCISM 6 0.0210
9 GENERALISED OEDEMA 216 0.0174
10 VULVOVAGINAL INFLAMMATION 8 0.0174
11 LYMPHOCYTE STIMULATION TEST POSITIVE 13 0.0162
12 THROMBOTIC CEREBRAL INFARCTION 6 0.0159
13 EMBOLIC CEREBRAL INFARCTION 10 0.0151
14 UPPER RESPIRATORY TRACT INFLAMMATION 17 0.0142
15 ALTERED STATE OF CONSCIOUSNESS 300 0.0138
16 HEAD DISCOMFORT 238 0.0134
17 HYPERURICAEMIA 48 0.0117
18 SACRAL PAIN 7 0.0115
19 HEAT ILLNESS 7 0.0104
20 ADRENAL ADENOMA 6 0.0101
21 LOW DENSITY LIPOPROTEIN ABNORMAL 6 0.0098
22 HAEMATEMESIS 247 0.0097
23 BRAIN CONTUSION 7 0.0096
24 IMMUNE-MEDIATED MYOSITIS 26 0.0094
25 CREATINE KINASE INCREASED 7 0.0091
26 PHOTOPHOBIA 171 0.0091
27 PRESYNCOPE 206 0.0085
28 LIPIDS ABNORMAL 6 0.0083
29 DIPLOPIA 210 0.0081
30 ASCITES 237 0.0081
31 THALAMUS HAEMORRHAGE 7 0.0080
32 HAEMORRHAGE SUBCUTANEOUS 27 0.0076
33 URINE KETONE BODY PRESENT 12 0.0076
34 PULMONARY SEPSIS 11 0.0076
35 HAEMATURIA 245 0.0071
36 EMBOLIC STROKE 23 0.0065
37 KETOSIS 7 0.0065
38 BLOOD KETONE BODY INCREASED 5 0.0064
39 HYPERPARATHYROIDISM SECONDARY 16 0.0064
40 DIABETIC NEPHROPATHY 14 0.0064
41 CEREBRAL INFARCTION 155 0.0063
42 CARDIO-RESPIRATORY ARREST 265 0.0063
43 CHRONIC HEPATITIS 5 0.0062
44 BRONCHITIS CHRONIC 15 0.0061
45 DYSBIOSIS 5 0.0061
46 BLINDNESS 238 0.0058
47 URETEROLITHIASIS 6 0.0057
48 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6 0.0054
49 ENTEROCOLITIS 31 0.0054
50 HEPATIC FUNCTION ABNORMAL 200 0.0054
51 AKINESIA 11 0.0053
52 PEMPHIGOID 40 0.0053
53 MYOPATHY 45 0.0052
54 CARDIAC FAILURE CHRONIC 22 0.0052
55 TOXIC ENCEPHALOPATHY 26 0.0051
56 DYSLIPIDAEMIA 26 0.0051
57 PYELONEPHRITIS ACUTE 10 0.0051
58 TINNITUS 234 0.0051
59 MYALGIA 859 0.0050
60 BLOOD CREATINE PHOSPHOKINASE INCREASED 145 0.0050
61 PRERENAL FAILURE 7 0.0050
62 SMALL INTESTINAL HAEMORRHAGE 10 0.0050
63 DROWNING 5 0.0049
64 SINUS NODE DYSFUNCTION 9 0.0049
65 LOW DENSITY LIPOPROTEIN INCREASED 38 0.0049
66 DIVERTICULUM INTESTINAL HAEMORRHAGIC 11 0.0049
67 COMA 232 0.0049
68 BLOOD CHOLESTEROL DECREASED 9 0.0048
69 CARDIAC FAILURE ACUTE 32 0.0048
70 NEUROGENIC BLADDER 10 0.0047
71 BONE DEMINERALISATION 5 0.0047
72 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
73 SUBCUTANEOUS HAEMATOMA 6 0.0047
74 SECONDARY ADRENOCORTICAL INSUFFICIENCY 7 0.0046
75 IMMUNE-MEDIATED HEPATIC DISORDER 9 0.0046
76 LACUNAR INFARCTION 11 0.0046
77 EYE PAIN 259 0.0046
78 NEPHROGENIC ANAEMIA 21 0.0045
79 BILE DUCT STONE 14 0.0044
80 FEMORAL NECK FRACTURE 22 0.0043
81 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0043
82 PHYSICAL DECONDITIONING 11 0.0043
83 PERIPHERAL ARTERY OCCLUSION 6 0.0043
84 BILE DUCT CANCER 5 0.0042
85 CEREBELLAR INFARCTION 7 0.0041
86 BLADDER NEOPLASM 7 0.0041
87 CAROTID ARTERY STENOSIS 14 0.0040
88 CHRONIC GASTRITIS 9 0.0040
89 GASTRIC POLYPS 9 0.0040
90 URINARY BLADDER HAEMORRHAGE 8 0.0038
91 INTERSTITIAL LUNG DISEASE 184 0.0038
92 TINEA PEDIS 6 0.0038
93 BENIGN PROSTATIC HYPERPLASIA 19 0.0037
94 PNEUMONIA BACTERIAL 33 0.0036
95 COLITIS ISCHAEMIC 24 0.0036
96 ENTERITIS INFECTIOUS 6 0.0035
97 DRUG ERUPTION 62 0.0035
98 RHABDOMYOLYSIS 145 0.0035
99 CARDIAC DISCOMFORT 7 0.0035
100 HYPERTONIC BLADDER 10 0.0035
101 DYSPNOEA AT REST 10 0.0034
102 HYPOPITUITARISM 6 0.0034
103 VASCULAR PSEUDOANEURYSM 6 0.0034
104 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 14 0.0034
105 PATELLA FRACTURE 8 0.0034
106 CORONARY ARTERY STENOSIS 17 0.0034
107 FEAR OF DISEASE 6 0.0034
108 ANGIOPLASTY 5 0.0033
109 HYPERCHOLESTEROLAEMIA 32 0.0033
110 REBOUND ACID HYPERSECRETION 10 0.0033
111 HIGH DENSITY LIPOPROTEIN DECREASED 11 0.0033
112 RADIATION PNEUMONITIS 7 0.0033
113 CALCULUS URINARY 5 0.0032
114 PROTEIN URINE PRESENT 16 0.0032
115 SMALL INTESTINAL PERFORATION 6 0.0032
116 CHOLECYSTITIS ACUTE 18 0.0032
117 POLYMYALGIA RHEUMATICA 10 0.0031
118 PSEUDOMEMBRANOUS COLITIS 7 0.0031
119 ADRENAL DISORDER 6 0.0031
120 ANTIPHOSPHOLIPID SYNDROME 5 0.0031
121 BLOOD LACTATE DEHYDROGENASE INCREASED 49 0.0031
122 ANGINA UNSTABLE 20 0.0031
123 SUBDURAL HAEMATOMA 44 0.0031
124 SPINAL COMPRESSION FRACTURE 25 0.0030
125 CONTRAINDICATED PRODUCT PRESCRIBED 5 0.0030
126 TACHYCARDIA 263 0.0030
127 PYELONEPHRITIS 25 0.0029
128 DISSEMINATED INTRAVASCULAR COAGULATION 40 0.0028
129 COMPRESSION FRACTURE 15 0.0028
130 DUODENAL ULCER HAEMORRHAGE 8 0.0028
131 PERIODONTITIS 6 0.0028
132 CAROTID ARTERY OCCLUSION 10 0.0027
133 GAMMA-GLUTAMYLTRANSFERASE INCREASED 60 0.0027
134 RHINITIS ALLERGIC 12 0.0027
135 ASPARTATE AMINOTRANSFERASE INCREASED 143 0.0027
136 SEPSIS 298 0.0027
137 METABOLIC ENCEPHALOPATHY 8 0.0027
138 THYROIDITIS 8 0.0027
139 BLOOD TRIGLYCERIDES INCREASED 47 0.0027
140 ANGINA PECTORIS 76 0.0026
141 RECTAL CANCER 8 0.0026
142 ANORGASMIA 7 0.0026
143 HEPATIC PAIN 11 0.0026
144 ERYTHEMA MULTIFORME 24 0.0026
145 COLITIS MICROSCOPIC 12 0.0025
146 DIPLEGIA 5 0.0025
147 SYNCOPE 251 0.0025
148 GLYCOSYLATED HAEMOGLOBIN INCREASED 62 0.0025
149 MYOSITIS 22 0.0024
150 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
151 DIVERTICULAR PERFORATION 5 0.0024
152 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
153 CHILLS 282 0.0024
154 LUMBAR SPINAL STENOSIS 7 0.0024
155 RETINAL ARTERY OCCLUSION 6 0.0024
156 PNEUMONIA ASPIRATION 59 0.0024
157 BLOOD UREA INCREASED 39 0.0023
158 LIVER DISORDER 101 0.0023
159 BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0023
160 STRESS CARDIOMYOPATHY 13 0.0022
161 RENAL IMPAIRMENT 186 0.0022
162 ALANINE AMINOTRANSFERASE INCREASED 135 0.0022
163 ORTHOPNOEA 7 0.0022
164 HAEMOGLOBIN INCREASED 10 0.0022
165 SPINAL STENOSIS 9 0.0022
166 AORTIC DISSECTION 9 0.0022
167 AMYLASE INCREASED 8 0.0022
168 LARGE INTESTINE POLYP 15 0.0022
169 COLON CANCER 32 0.0021
170 ATYPICAL FEMUR FRACTURE 6 0.0021
171 IMMUNE THROMBOCYTOPENIC PURPURA 6 0.0021
172 CARDIAC TAMPONADE 10 0.0021
173 BLOOD PRESSURE INCREASED 319 0.0021
174 HYPOGLYCAEMIC COMA 6 0.0021
175 DIABETIC RETINOPATHY 7 0.0021
176 HEPATITIS FULMINANT 6 0.0020
177 ODYNOPHAGIA 12 0.0020
178 BRAIN HERNIATION 6 0.0020
179 GASTRIC ULCER HAEMORRHAGE 11 0.0020
180 EMBOLISM VENOUS 6 0.0020
181 ANURIA 17 0.0020
182 END STAGE RENAL DISEASE 36 0.0020
183 FIBRIN D DIMER INCREASED 7 0.0020
184 ACUTE MYOCARDIAL INFARCTION 58 0.0020
185 RETINAL HAEMORRHAGE 14 0.0020
186 ISCHAEMIC CARDIOMYOPATHY 6 0.0020
187 CANCER PAIN 5 0.0020
188 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
189 BLOOD CHLORIDE DECREASED 5 0.0019
190 DECREASED APPETITE 450 0.0019
191 BLOOD ALKALINE PHOSPHATASE INCREASED 48 0.0019
192 ACUTE CORONARY SYNDROME 16 0.0019
193 EOSINOPHIL COUNT INCREASED 16 0.0019
194 BLOOD URIC ACID INCREASED 11 0.0019
195 SUDDEN DEATH 20 0.0019
196 LIP OEDEMA 8 0.0019
197 BLOOD CHOLESTEROL INCREASED 87 0.0019
198 SKIN EROSION 6 0.0019
199 CARDIAC FAILURE 149 0.0019
200 HYPERKALAEMIA 65 0.0019
201 HEPATITIS ACUTE 12 0.0018
202 DUODENAL ULCER 13 0.0018
203 HYPERLIPIDAEMIA 22 0.0018
204 THROMBOSIS IN DEVICE 6 0.0018
205 PARONYCHIA 8 0.0018
206 ORGANISING PNEUMONIA 9 0.0018
207 C-REACTIVE PROTEIN INCREASED 66 0.0018
208 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
209 DIABETES MELLITUS INADEQUATE CONTROL 32 0.0018
210 PANIC DISORDER 7 0.0018
211 HYPERNATRAEMIA 9 0.0018
212 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
213 ARTERIAL OCCLUSIVE DISEASE 14 0.0018
214 IDIOPATHIC PULMONARY FIBROSIS 7 0.0018
215 SUBARACHNOID HAEMORRHAGE 18 0.0018
216 HEPATIC CYST 6 0.0018
217 CHOLECYSTITIS 21 0.0018
218 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
219 ANAEMIA 334 0.0017
220 CHRONIC KIDNEY DISEASE 132 0.0017
221 HYDRONEPHROSIS 13 0.0017
222 VENTRICULAR EXTRASYSTOLES 18 0.0017
223 TENDON RUPTURE 21 0.0017
224 JAUNDICE CHOLESTATIC 6 0.0017
225 GASTROINTESTINAL PERFORATION 7 0.0017
226 VISION BLURRED 231 0.0017
227 NON-SMALL CELL LUNG CANCER 8 0.0017
228 DRUG-INDUCED LIVER INJURY 52 0.0017
229 BLOOD ALBUMIN DECREASED 13 0.0016
230 TENSION HEADACHE 7 0.0016
231 COVID-19 PNEUMONIA 19 0.0016
232 RETINOPATHY 6 0.0016
233 CORONARY ARTERY OCCLUSION 22 0.0016
234 SHOCK HAEMORRHAGIC 13 0.0016
235 AUTOIMMUNE THYROIDITIS 6 0.0016
236 DIABETIC KETOACIDOSIS 38 0.0016
237 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
238 MUSCLE SPASMS 288 0.0016
239 ILEUS PARALYTIC 7 0.0016
240 ENTERITIS 10 0.0016
241 PULMONARY TOXICITY 11 0.0016
242 HYPOALBUMINAEMIA 12 0.0015
243 HYPERTRIGLYCERIDAEMIA 9 0.0015
244 HYPOGLYCAEMIA 74 0.0015
245 NEPHROPATHY 14 0.0015
246 TUBULOINTERSTITIAL NEPHRITIS 28 0.0015
247 RHINITIS 12 0.0015
248 ARTERIOSCLEROSIS 14 0.0015
249 SPINAL OSTEOARTHRITIS 13 0.0015
250 ABDOMINAL PAIN UPPER 304 0.0015
251 EYELID PTOSIS 15 0.0015
252 NEUTROPHIL COUNT DECREASED 60 0.0015
253 PERIPHERAL ISCHAEMIA 6 0.0015
254 BRONCHOPNEUMONIA 5 0.0015
255 NEPHROTIC SYNDROME 10 0.0015
256 INSOMNIA 388 0.0015
257 HYPERGLYCAEMIA 53 0.0015
258 MUSCLE INJURY 12 0.0014
259 HEMIPLEGIA 12 0.0014
260 HYPOTHYROIDISM 46 0.0014
261 AUTOIMMUNE HEPATITIS 10 0.0014
262 AORTIC STENOSIS 5 0.0014
263 SOMNOLENCE 288 0.0014
264 HYPOCALCAEMIA 27 0.0014
265 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
266 PLATELET COUNT DECREASED 151 0.0014
267 MUSCLE FATIGUE 6 0.0014
268 DRUG INTERACTION 223 0.0014
269 HEPATIC ENZYME ABNORMAL 7 0.0014
270 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
271 FAECES SOFT 10 0.0014
272 DIVERTICULUM INTESTINAL 6 0.0014
273 GASTROENTERITIS 20 0.0014
274 CEREBRAL HAEMORRHAGE 49 0.0014
275 MELAENA 30 0.0014
276 GINGIVAL SWELLING 6 0.0014
277 MUSCLE DISORDER 11 0.0014
278 ALCOHOL USE 5 0.0014
279 CATHETERISATION CARDIAC 6 0.0014
280 FALL 449 0.0013
281 CARDIAC DYSFUNCTION 5 0.0013
282 RENAL DISORDER 62 0.0013
283 BLOOD LACTIC ACID INCREASED 7 0.0013
284 MYOCARDIAL ISCHAEMIA 15 0.0013
285 IMMUNE THROMBOCYTOPENIA 6 0.0013
286 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
287 ABDOMINAL PAIN 303 0.0013
288 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
289 IRON DEFICIENCY ANAEMIA 12 0.0013
290 PNEUMOCYSTIS JIROVECII PNEUMONIA 13 0.0013
291 TENDONITIS 20 0.0013
292 TOXIC SKIN ERUPTION 13 0.0013
293 CHOLANGITIS 8 0.0013
294 GASTRITIS EROSIVE 6 0.0013
295 PAPULE 9 0.0013
296 DERMATITIS ALLERGIC 16 0.0013
297 DRUG LEVEL INCREASED 21 0.0013
298 PYREXIA 437 0.0013
299 ARTHRALGIA 525 0.0013
300 AZOTAEMIA 5 0.0013
301 METABOLIC ACIDOSIS 40 0.0012
302 FACE OEDEMA 21 0.0012
303 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
304 GENERALISED ERYTHEMA 7 0.0012
305 MUSCULAR WEAKNESS 139 0.0012
306 OROPHARYNGEAL DISCOMFORT 11 0.0012
307 SHOCK 28 0.0012
308 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
309 SPRUE-LIKE ENTEROPATHY 6 0.0012
310 TRANSIENT ISCHAEMIC ATTACK 41 0.0012
311 WALKING AID USER 8 0.0012
312 MOUTH SWELLING 7 0.0012
313 COUGH 340 0.0012
314 LIVER FUNCTION TEST INCREASED 26 0.0012
315 PAROSMIA 9 0.0012
316 RESPIRATORY TRACT INFECTION 31 0.0012
317 JAUNDICE 32 0.0012
318 PLEURISY 7 0.0012
319 LIPASE INCREASED 9 0.0012
320 BLOOD POTASSIUM INCREASED 19 0.0012
321 ANAPHYLACTIC SHOCK 30 0.0012
322 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
323 OEDEMA 63 0.0012
324 ASTHENIA 434 0.0012
325 PRURITUS 443 0.0012
326 CHROMATURIA 26 0.0012
327 DERMATITIS ACNEIFORM 7 0.0011
328 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
329 URINE OUTPUT DECREASED 10 0.0011
330 DIABETES MELLITUS 87 0.0011
331 PIGMENTATION DISORDER 7 0.0011
332 BLOOD CREATININE INCREASED 74 0.0011
333 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
334 OLIGURIA 7 0.0011
335 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
336 CORONARY ARTERY DISEASE 34 0.0011
337 VITREOUS FLOATERS 11 0.0011
338 EYELID OEDEMA 13 0.0011
339 QUALITY OF LIFE DECREASED 15 0.0011
340 LACTIC ACIDOSIS 36 0.0011
341 HYPOKALAEMIA 51 0.0011
342 POLLAKIURIA 46 0.0011
343 PRESCRIBED UNDERDOSE 22 0.0011
344 HYDROCEPHALUS 6 0.0011
345 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
346 LYMPHOMA 17 0.0011
347 BLOOD PRESSURE DECREASED 73 0.0011
348 ABDOMINAL HERNIA 5 0.0011
349 DYSPNOEA EXERTIONAL 41 0.0011
350 MUSCLE RIGIDITY 13 0.0011
351 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
352 TRANSAMINASES INCREASED 24 0.0011
353 LYMPHOCYTE COUNT DECREASED 19 0.0011
354 PANCREATIC CARCINOMA 31 0.0011
355 PNEUMOTHORAX 17 0.0011
356 SENSATION OF FOREIGN BODY 9 0.0011
357 PRURITUS GENERALISED 23 0.0011
358 MALAISE 466 0.0011
359 SQUAMOUS CELL CARCINOMA 10 0.0011
360 INADEQUATE ANALGESIA 9 0.0011
361 GASTRIC ULCER 20 0.0011
362 ACUTE KIDNEY INJURY 161 0.0011
363 MUSCLE TIGHTNESS 17 0.0010
364 OSTEOMYELITIS 19 0.0010
365 DIZZINESS 523 0.0010
366 PHARYNGITIS 13 0.0010
367 ILEUS 13 0.0010
368 CORONARY ARTERY BYPASS 6 0.0010
369 MUSCLE STRAIN 9 0.0010
370 DIFFUSE LARGE B-CELL LYMPHOMA 8 0.0010
371 STEVENS-JOHNSON SYNDROME 23 0.0010
372 HEPATIC ENZYME INCREASED 70 0.0010
373 BLOOD TESTOSTERONE DECREASED 7 0.0010
374 PANCREATITIS ACUTE 23 0.0010
375 LUNG INFILTRATION 9 0.0010
376 WRONG TECHNIQUE IN DRUG USAGE PROCESS 37 0.0010
377 AFFECTIVE DISORDER 8 0.0010
378 MIDDLE INSOMNIA 19 0.0010
379 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
380 DRUG INTOLERANCE 98 0.0010
381 CATARACT OPERATION 6 0.0010
382 BACTERAEMIA 12 0.0010
383 DIABETIC NEUROPATHY 5 0.0010
384 HAEMOPTYSIS 28 0.0010
385 SYMPTOM RECURRENCE 6 0.0010
386 BLOOD BILIRUBIN INCREASED 27 0.0010
387 RIGHT VENTRICULAR FAILURE 7 0.0010
388 DIARRHOEA 644 0.0010
389 BACK PAIN 230 0.0010
390 SEASONAL ALLERGY 14 0.0010
391 HYPERTENSIVE CRISIS 11 0.0010
392 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
393 ORAL CANDIDIASIS 13 0.0010
394 INGUINAL HERNIA 6 0.0010
395 CORONARY ARTERIAL STENT INSERTION 5 0.0010
396 POST PROCEDURAL INFECTION 8 0.0010
397 DYSARTHRIA 37 0.0010
398 BLOOD CALCIUM DECREASED 11 0.0010
399 DYSURIA 36 0.0010
400 RENAL INJURY 29 0.0010
401 HYPERCALCAEMIA 12 0.0010
402 PLEURAL EFFUSION 59 0.0010
403 LIMB DISCOMFORT 30 0.0010
404 VENTRICULAR TACHYCARDIA 16 0.0010
405 VISUAL FIELD DEFECT 7 0.0010
406 HEPATIC STEATOSIS 18 0.0010
407 ATRIAL FIBRILLATION 94 0.0010
408 DERMATITIS CONTACT 11 0.0010
409 INTERNAL HAEMORRHAGE 11 0.0010
410 PRE-EXISTING CONDITION IMPROVED 6 0.0010
411 PRODUCT ODOUR ABNORMAL 10 0.0010
412 PHOTOPSIA 6 0.0009
413 PERIPHERAL COLDNESS 13 0.0009
414 CYSTITIS 30 0.0009
415 CATARACT 56 0.0009
416 BODY HEIGHT DECREASED 10 0.0009
417 HYPOMAGNESAEMIA 13 0.0009
418 PAIN IN EXTREMITY 275 0.0009
419 GAIT DISTURBANCE 178 0.0009
420 DEHYDRATION 124 0.0009
421 OSTEOPENIA 14 0.0009
422 RENAL FAILURE 122 0.0009
423 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
424 CELLULITIS 46 0.0009
425 GROIN PAIN 8 0.0009
426 ASTHENOPIA 5 0.0009
427 TUMOUR LYSIS SYNDROME 8 0.0009
428 PERICARDIAL EFFUSION 21 0.0009
429 ADRENAL INSUFFICIENCY 11 0.0009
430 NEURALGIA 22 0.0009
431 PURPURA 8 0.0009
432 CONTUSION 87 0.0009
433 MOVEMENT DISORDER 29 0.0009
434 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
435 VENTRICULAR FIBRILLATION 10 0.0009
436 BASAL CELL CARCINOMA 14 0.0009
437 SEPTIC SHOCK 39 0.0009
438 GASTROOESOPHAGEAL REFLUX DISEASE 72 0.0009
439 HAEMARTHROSIS 8 0.0009
440 SKIN INFECTION 10 0.0009
441 ACUTE PULMONARY OEDEMA 5 0.0009
442 SLEEP APNOEA SYNDROME 17 0.0009
443 HEADACHE 556 0.0009
444 RENAL CYST 7 0.0009
445 RIB FRACTURE 18 0.0009
446 NEUROPATHY PERIPHERAL 83 0.0009
447 GASTRIC CANCER 22 0.0009
448 UROSEPSIS 8 0.0009
449 LARGE INTESTINE PERFORATION 6 0.0009
450 CONJUNCTIVITIS 16 0.0009
451 OEDEMA PERIPHERAL 105 0.0009
452 HYPOPHAGIA 22 0.0009
453 EXTRASYSTOLES 6 0.0009
454 DYSPNOEA 486 0.0009
455 ROTATOR CUFF SYNDROME 11 0.0009
456 FLANK PAIN 8 0.0009
457 HYPERAESTHESIA 7 0.0009
458 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
459 CYTOKINE RELEASE SYNDROME 17 0.0008
460 MUSCULOSKELETAL CHEST PAIN 13 0.0008
461 MUSCULOSKELETAL PAIN 44 0.0008
462 THIRST 15 0.0008
463 CARDIAC PACEMAKER INSERTION 5 0.0008
464 HERPES ZOSTER 48 0.0008
465 PULMONARY CONGESTION 11 0.0008
466 BLOOD POTASSIUM DECREASED 25 0.0008
467 INFUSION SITE ERYTHEMA 7 0.0008
468 DIVERTICULITIS 23 0.0008
469 BRADYCARDIA 44 0.0008
470 DERMATITIS BULLOUS 6 0.0008
471 OESOPHAGITIS 9 0.0008
472 DYSSTASIA 24 0.0008
473 RENAL TUBULAR NECROSIS 8 0.0008
474 HYPOPHOSPHATAEMIA 6 0.0008
475 CONSTIPATION 177 0.0008
476 LIGAMENT SPRAIN 8 0.0008
477 OSTEONECROSIS OF JAW 20 0.0008
478 IMPAIRED GASTRIC EMPTYING 11 0.0008
479 HAIR COLOUR CHANGES 10 0.0008
480 EOSINOPHILIA 14 0.0008
481 VOMITING 375 0.0008
482 MITRAL VALVE INCOMPETENCE 9 0.0008
483 COLD SWEAT 14 0.0008
484 BLOOD PRESSURE FLUCTUATION 19 0.0008
485 HYPOTHERMIA 8 0.0008
486 EAR INFECTION 21 0.0008
487 AORTIC ANEURYSM 6 0.0008
488 FACIAL PAIN 7 0.0008
489 ARRHYTHMIA 37 0.0008
490 NEUTROPHIL COUNT INCREASED 8 0.0008
491 DEVICE RELATED INFECTION 12 0.0008
492 METASTASES TO LUNG 9 0.0008
493 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
494 DELIRIUM 27 0.0008
495 ATRIOVENTRICULAR BLOCK 6 0.0008
496 FLATULENCE 44 0.0008
497 PRODUCTIVE COUGH 37 0.0008
498 WHITE BLOOD CELL COUNT DECREASED 84 0.0008
499 SKIN ULCER 20 0.0008
500 PERITONITIS 16 0.0008
501 CARDIAC FAILURE CONGESTIVE 62 0.0008
502 EAR PAIN 15 0.0008
503 CHOKING 15 0.0008
504 FEBRILE NEUTROPENIA 51 0.0008
505 URINARY TRACT INFECTION 131 0.0008
506 PNEUMONIA 248 0.0008
507 MULTIPLE ALLERGIES 6 0.0008
508 RETINAL DETACHMENT 7 0.0008
509 CORONAVIRUS INFECTION 5 0.0008
510 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
511 BLOOD PRESSURE ABNORMAL 15 0.0008
512 RENAL FAILURE ACUTE 32 0.0008
513 PALPITATIONS 88 0.0008
514 FATIGUE 585 0.0008
515 WRIST FRACTURE 9 0.0008
516 URINARY RETENTION 25 0.0007
517 HAIR TEXTURE ABNORMAL 10 0.0007
518 IRRITABLE BOWEL SYNDROME 16 0.0007
519 HYPONATRAEMIA 42 0.0007
520 LACERATION 7 0.0007
521 STENT PLACEMENT 6 0.0007
522 POOR QUALITY SLEEP 16 0.0007
523 URINARY INCONTINENCE 22 0.0007
524 CHEST DISCOMFORT 76 0.0007
525 BRONCHIECTASIS 5 0.0007
526 DECREASED ACTIVITY 8 0.0007
527 INFLUENZA LIKE ILLNESS 61 0.0007
528 ERECTILE DYSFUNCTION 19 0.0007
529 FRACTURE 14 0.0007
530 FAECES DISCOLOURED 16 0.0007
531 BLOOD URINE PRESENT 14 0.0007
532 MYOCARDIAL INFARCTION 128 0.0007
533 RASH GENERALISED 19 0.0007
534 NAUSEA 580 0.0007
535 GINGIVAL BLEEDING 10 0.0007
536 HICCUPS 6 0.0007
537 ASPIRATION 8 0.0007
538 COGNITIVE DISORDER 34 0.0007
539 ECONOMIC PROBLEM 11 0.0007
540 GOUT 13 0.0007
541 ANHEDONIA 19 0.0007
542 VIRAL INFECTION 24 0.0007
543 PULMONARY HYPERTENSION 15 0.0007
544 GASTROENTERITIS VIRAL 13 0.0007
545 AUTOIMMUNE DISORDER 7 0.0007
546 BRONCHITIS 53 0.0007
547 HAEMODIALYSIS 6 0.0007
548 SINUS DISORDER 14 0.0007
549 BLADDER DISORDER 7 0.0007
550 FACIAL PARALYSIS 6 0.0007
551 MYOCARDITIS 8 0.0007
552 EMPHYSEMA 7 0.0007
553 CONTRAINDICATED PRODUCT ADMINISTERED 21 0.0007
554 RASH 302 0.0007
555 SINUSITIS 71 0.0007
556 TASTE DISORDER 14 0.0007
557 BLOOD SODIUM DECREASED 13 0.0007
558 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49 0.0007
559 DRY THROAT 7 0.0007
560 LIVER FUNCTION TEST ABNORMAL 20 0.0007
561 VASCULITIS 8 0.0007
562 NAIL DISORDER 6 0.0007
563 TYPE 2 DIABETES MELLITUS 23 0.0007
564 FEELING COLD 19 0.0007
565 RHINORRHOEA 44 0.0007
566 NECK PAIN 38 0.0007
567 DEMENTIA 19 0.0007
568 BLINDNESS TRANSIENT 5 0.0007
569 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 137 0.0007
570 CEREBRAL DISORDER 5 0.0007
571 ACUTE RESPIRATORY FAILURE 13 0.0007
572 BLOOD GLUCOSE INCREASED 127 0.0007
573 HEPATOTOXICITY 15 0.0007
574 LOSS OF CONSCIOUSNESS 86 0.0007
575 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
576 RESPIRATORY DISORDER 20 0.0007
577 TRANSFUSION 7 0.0007
578 LIMB INJURY 18 0.0007
579 JOINT DISLOCATION 7 0.0007
580 TACHYPNOEA 9 0.0007
581 CYTOMEGALOVIRUS INFECTION 11 0.0007
582 OSTEOARTHRITIS 28 0.0007
583 OPTIC NEURITIS 6 0.0007
584 NOCTURIA 8 0.0007
585 GASTROINTESTINAL HAEMORRHAGE 55 0.0007
586 OSTEOPOROSIS 27 0.0007
587 SKIN LESION 18 0.0007
588 ABDOMINAL DISCOMFORT 110 0.0007
589 HYPOAESTHESIA 98 0.0007
590 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
591 ENCEPHALOPATHY 16 0.0007
592 NERVE COMPRESSION 6 0.0006
593 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
594 CHEST PAIN 120 0.0006
595 ABASIA 16 0.0006
596 CARPAL TUNNEL SYNDROME 9 0.0006
597 APPENDICITIS 6 0.0006
598 CHOLELITHIASIS 21 0.0006
599 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
600 BONE PAIN 37 0.0006
601 SCIATICA 10 0.0006
602 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
603 ATRIAL FLUTTER 5 0.0006
604 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
605 THERAPY CESSATION 32 0.0006
606 PARAESTHESIA 98 0.0006
607 DYSGEUSIA 46 0.0006
608 AMNESIA 40 0.0006
609 HYPERTENSION 130 0.0006
610 CHOLECYSTECTOMY 7 0.0006
611 LUNG DISORDER 30 0.0006
612 ARTHRITIS 48 0.0006
613 JOINT STIFFNESS 16 0.0006
614 HOSPICE CARE 6 0.0006
615 NIGHTMARE 21 0.0006
616 ABDOMINAL DISTENSION 63 0.0006
617 AGEUSIA 15 0.0006
618 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
619 EYE HAEMORRHAGE 8 0.0006
620 INTENTIONAL DOSE OMISSION 17 0.0006
621 MUSCULOSKELETAL STIFFNESS 52 0.0006
622 AGRANULOCYTOSIS 11 0.0006
623 PRODUCT TASTE ABNORMAL 8 0.0006
624 PANCYTOPENIA 33 0.0006
625 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
626 HELICOBACTER INFECTION 6 0.0006
627 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
628 TEMPERATURE INTOLERANCE 6 0.0006
629 ANKLE FRACTURE 9 0.0006
630 MUSCULOSKELETAL DISCOMFORT 10 0.0006
631 FOOT FRACTURE 11 0.0006
632 BLOOD MAGNESIUM DECREASED 5 0.0006
633 HAEMATOMA 15 0.0006
634 EYE DISCHARGE 6 0.0006
635 SWOLLEN TONGUE 18 0.0006
636 EPISTAXIS 43 0.0006
637 BRAIN FOG 9 0.0006
638 RASH PRURITIC 31 0.0006
639 FLUSHING 58 0.0006
640 GASTRITIS 15 0.0006
641 HEART RATE DECREASED 20 0.0006
642 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
643 PRESCRIBED OVERDOSE 11 0.0006
644 INCONTINENCE 6 0.0006
645 ANGIOEDEMA 25 0.0006
646 DYSPHONIA 33 0.0006
647 HAEMORRHOIDS 11 0.0006
648 LACRIMATION INCREASED 17 0.0006
649 SENSORY DISTURBANCE 9 0.0006
650 EPILEPSY 17 0.0006
651 WEIGHT DECREASED 155 0.0006
652 PARAESTHESIA ORAL 8 0.0006
653 COLITIS 21 0.0006
654 MUSCLE ATROPHY 7 0.0006
655 SKIN LACERATION 6 0.0006
656 RESTLESS LEGS SYNDROME 10 0.0005
657 FEMUR FRACTURE 17 0.0005
658 RESPIRATORY FAILURE 40 0.0005
659 TREATMENT NONCOMPLIANCE 30 0.0005
660 PRODUCT ADMINISTRATION ERROR 11 0.0005
661 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 98 0.0005
662 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
663 NASOPHARYNGITIS 100 0.0005
664 DRY MOUTH 44 0.0005
665 INJECTION SITE INDURATION 7 0.0005
666 RASH MACULO-PAPULAR 12 0.0005
667 MEMORY IMPAIRMENT 74 0.0005
668 GAIT INABILITY 18 0.0005
669 MALNUTRITION 6 0.0005
670 PULMONARY OEDEMA 24 0.0005
671 RASH PAPULAR 12 0.0005
672 LUNG NEOPLASM MALIGNANT 22 0.0005
673 FIBROMYALGIA 13 0.0005
674 NEPHROPATHY TOXIC 6 0.0005
675 CANDIDA INFECTION 9 0.0005
676 EYE INFECTION 6 0.0005
677 HEART RATE IRREGULAR 12 0.0005
678 HYPOAESTHESIA ORAL 8 0.0005
679 INTESTINAL OBSTRUCTION 20 0.0005
680 COVID-19 93 0.0005
681 BLOOD COUNT ABNORMAL 8 0.0005
682 MALIGNANT NEOPLASM PROGRESSION 54 0.0005
683 PROTEINURIA 10 0.0005
684 ROAD TRAFFIC ACCIDENT 22 0.0005
685 MICTURITION URGENCY 6 0.0005
686 PROSTATE CANCER 42 0.0005
687 ASTHMA 59 0.0005
688 SINUS CONGESTION 7 0.0005
689 ORTHOSTATIC HYPOTENSION 9 0.0005
690 LOCAL SWELLING 9 0.0005
691 PERIPHERAL SWELLING 79 0.0005
692 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
693 FLUID RETENTION 26 0.0005
694 VERTIGO 31 0.0005
695 HUNGER 7 0.0005
696 GASTROINTESTINAL DISORDER 45 0.0005
697 INFLUENZA 56 0.0005
698 APHONIA 7 0.0005
699 FEELING ABNORMAL 120 0.0005
700 ALOPECIA 98 0.0005
701 OXYGEN SATURATION DECREASED 28 0.0005
702 HEPATIC FAILURE 15 0.0005
703 TOOTHACHE 9 0.0005
704 PRODUCT PHYSICAL ISSUE 10 0.0005
705 STOMATITIS 30 0.0005
706 BONE DISORDER 9 0.0005
707 NASAL CONGESTION 29 0.0005
708 DIALYSIS 7 0.0005
709 INJECTION SITE PRURITUS 33 0.0005
710 BACK DISORDER 8 0.0005
711 EAR DISCOMFORT 5 0.0005
712 PAIN 299 0.0005
713 FEAR 13 0.0005
714 INFUSION RELATED REACTION 32 0.0005
715 TOOTH EXTRACTION 6 0.0005
716 LIP SWELLING 16 0.0005
717 COAGULOPATHY 8 0.0005
718 APATHY 7 0.0005
719 DYSPEPSIA 47 0.0005
720 DEEP VEIN THROMBOSIS 31 0.0005
721 KNEE ARTHROPLASTY 10 0.0005
722 ABDOMINAL PAIN LOWER 12 0.0005
723 WEIGHT INCREASED 106 0.0005
724 FEELING HOT 29 0.0005
725 TREMOR 78 0.0005
726 RETCHING 10 0.0005
727 CHOLESTASIS 9 0.0005
728 HAEMORRHAGE INTRACRANIAL 7 0.0005
729 NIGHT SWEATS 15 0.0005
730 ERUCTATION 9 0.0005
731 INFLAMMATION 24 0.0005
732 APHASIA 14 0.0005
733 ERYTHEMA 95 0.0005
734 TOOTH INFECTION 6 0.0005
735 RED BLOOD CELL COUNT DECREASED 13 0.0005
736 URTICARIA 76 0.0005
737 HALLUCINATION 34 0.0005
738 HOT FLUSH 34 0.0005
739 CONDITION AGGRAVATED 137 0.0005
740 EJECTION FRACTION DECREASED 7 0.0004
741 NEUTROPENIA 61 0.0004
742 INJECTION SITE URTICARIA 11 0.0004
743 ISCHAEMIC STROKE 8 0.0004
744 THROMBOCYTOPENIA 50 0.0004
745 MOBILITY DECREASED 32 0.0004
746 SURGERY 26 0.0004
747 UVEITIS 6 0.0004
748 LEUKOCYTOSIS 8 0.0004
749 BALANCE DISORDER 38 0.0004
750 JOINT SWELLING 53 0.0004
751 DEPRESSION 99 0.0004
752 HEART RATE INCREASED 43 0.0004
753 HYPOTENSION 87 0.0004
754 INJECTION SITE MASS 16 0.0004
755 COORDINATION ABNORMAL 6 0.0004
756 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
757 BURNING SENSATION 30 0.0004
758 BLISTER 24 0.0004
759 HEPATIC CIRRHOSIS 8 0.0004
760 SLEEP DISORDER 30 0.0004
761 LYMPHADENOPATHY 15 0.0004
762 INTENTIONAL PRODUCT MISUSE 37 0.0004
763 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
764 OCULAR HYPERAEMIA 20 0.0004
765 BLOOD IRON DECREASED 5 0.0004
766 OROPHARYNGEAL PAIN 39 0.0004
767 HAEMORRHAGE 44 0.0004
768 DRY EYE 21 0.0004
769 DEAFNESS 11 0.0004
770 FEELING JITTERY 8 0.0004
771 HYPERHIDROSIS 54 0.0004
772 PARALYSIS 6 0.0004
773 RECTAL HAEMORRHAGE 18 0.0004
774 HYPERSOMNIA 12 0.0004
775 RASH ERYTHEMATOUS 20 0.0004
776 CARDIOGENIC SHOCK 6 0.0004
777 IMPAIRED QUALITY OF LIFE 6 0.0004
778 LETHARGY 24 0.0004
779 GLAUCOMA 8 0.0004
780 BONE DENSITY DECREASED 13 0.0004
781 ANOSMIA 6 0.0004
782 HYPERTHYROIDISM 6 0.0004
783 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
784 DRUG EFFECT INCOMPLETE 15 0.0004
785 BURSITIS 5 0.0004
786 UNDERDOSE 30 0.0004
787 SKIN FISSURES 8 0.0004
788 LIVER INJURY 10 0.0004
789 CARDIOMEGALY 5 0.0004
790 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
791 HAEMATOCRIT DECREASED 8 0.0004
792 CYST 5 0.0004
793 EXTRAPYRAMIDAL DISORDER 10 0.0004
794 THROAT IRRITATION 18 0.0004
795 INJECTION SITE BRUISING 32 0.0004
796 OFF LABEL USE 351 0.0004
797 ABNORMAL DREAMS 11 0.0004
798 PANCREATITIS 21 0.0004
799 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
800 BLOOD GLUCOSE DECREASED 19 0.0004
801 FEEDING DISORDER 8 0.0004
802 CARDIOVASCULAR DISORDER 10 0.0004
803 NEPHROLITHIASIS 18 0.0004
804 HIP ARTHROPLASTY 6 0.0004
805 BLADDER CANCER 23 0.0004
806 FUNGAL INFECTION 13 0.0004
807 HAEMOGLOBIN DECREASED 40 0.0004
808 THYROID DISORDER 6 0.0004
809 PAIN IN JAW 11 0.0004
810 EYE PRURITUS 13 0.0004
811 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
812 PRODUCT USE COMPLAINT 6 0.0004
813 HAEMATOCHEZIA 21 0.0004
814 MOUTH ULCERATION 8 0.0004
815 HEAD INJURY 12 0.0004
816 BLOOD GLUCOSE ABNORMAL 7 0.0004
817 HALLUCINATION, VISUAL 8 0.0004
818 GASTRIC DISORDER 13 0.0004
819 DISCOMFORT 23 0.0004
820 ABSCESS 6 0.0004
821 CARDIAC ARREST 31 0.0004
822 BACTERIAL INFECTION 7 0.0004
823 IMPAIRED WORK ABILITY 8 0.0004
824 RASH MACULAR 13 0.0004
825 PAIN OF SKIN 10 0.0004
826 VISUAL IMPAIRMENT 46 0.0004
827 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
828 DYSKINESIA 15 0.0004
829 MUSCULOSKELETAL DISORDER 7 0.0004
830 INCREASED APPETITE 7 0.0004
831 METASTASES TO BONE 6 0.0004
832 MULTIPLE FRACTURES 6 0.0004
833 EYE DISORDER 12 0.0004
834 PRODUCT SUBSTITUTION ISSUE 21 0.0004
835 POST PROCEDURAL COMPLICATION 7 0.0004
836 PHOTOSENSITIVITY REACTION 6 0.0004
837 ECZEMA 19 0.0004
838 ARTHROPATHY 20 0.0004
839 SKIN DISORDER 12 0.0004
840 DEPRESSED MOOD 19 0.0004
841 KIDNEY INFECTION 7 0.0004
842 BLOOD TEST ABNORMAL 5 0.0004
843 SEIZURE 41 0.0004
844 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
845 CARDIAC DISORDER 33 0.0004
846 NERVOUS SYSTEM DISORDER 11 0.0004
847 CIRCULATORY COLLAPSE 6 0.0004
848 HEPATITIS 9 0.0004
849 PRODUCT USE ISSUE 66 0.0004
850 SCAR 6 0.0004
851 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
852 BONE MARROW FAILURE 7 0.0003
853 METASTASES TO LIVER 6 0.0003
854 ANXIETY 97 0.0003
855 OSTEONECROSIS 11 0.0003
856 CONFUSIONAL STATE 54 0.0003
857 SKIN EXFOLIATION 28 0.0003
858 INFECTION 48 0.0003
859 SWELLING 31 0.0003
860 PNEUMONITIS 9 0.0003
861 EYE IRRITATION 19 0.0003
862 MENTAL IMPAIRMENT 8 0.0003
863 RESTLESSNESS 12 0.0003
864 DYSPHAGIA 31 0.0003
865 INJECTION SITE SWELLING 25 0.0003
866 RESPIRATORY DISTRESS 9 0.0003
867 DRUG ADMINISTRATION ERROR 10 0.0003
868 DELUSION 5 0.0003
869 THERAPY INTERRUPTED 23 0.0003
870 PRODUCT DOSE OMISSION 21 0.0003
871 ACUTE MYELOID LEUKAEMIA 5 0.0003
872 APPLICATION SITE PAIN 7 0.0003
873 PULMONARY EMBOLISM 30 0.0003
874 EMOTIONAL DISTRESS 38 0.0003
875 SUICIDE ATTEMPT 19 0.0003
876 GLOSSODYNIA 7 0.0003
877 ORAL PAIN 7 0.0003
878 HYPERSENSITIVITY 58 0.0003
879 SEROTONIN SYNDROME 6 0.0003
880 LOWER LIMB FRACTURE 6 0.0003
881 APPLICATION SITE PRURITUS 7 0.0003
882 PRODUCT AVAILABILITY ISSUE 7 0.0003
883 ORAL HERPES 6 0.0003
884 MUCOSAL INFLAMMATION 8 0.0003
885 LABORATORY TEST ABNORMAL 9 0.0003
886 STAPHYLOCOCCAL INFECTION 10 0.0003
887 DISORIENTATION 12 0.0003
888 LEUKOPENIA 15 0.0003
889 DRY SKIN 40 0.0003
890 IRRITABILITY 18 0.0003
891 SWELLING FACE 19 0.0003
892 RHEUMATOID ARTHRITIS 33 0.0003
893 WHEEZING 17 0.0003
894 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
895 HYPOXIA 10 0.0003
896 PLASMA CELL MYELOMA 11 0.0003
897 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
898 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
899 ILL-DEFINED DISORDER 17 0.0003
900 DRUG EFFECT DECREASED 15 0.0003
901 MYELOSUPPRESSION 10 0.0003
902 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
903 INJECTION SITE ERYTHEMA 34 0.0003
904 THROMBOSIS 22 0.0003
905 DISEASE RECURRENCE 13 0.0003
906 ILLNESS 28 0.0003
907 DISEASE PROGRESSION 32 0.0003
908 TOOTH DISORDER 6 0.0003
909 INTENTIONAL OVERDOSE 17 0.0003
910 THERAPEUTIC RESPONSE DECREASED 16 0.0003
911 PRODUCT USE IN UNAPPROVED INDICATION 65 0.0003
912 MIGRAINE 25 0.0003
913 FREQUENT BOWEL MOVEMENTS 7 0.0003
914 HYPOACUSIS 11 0.0003
915 CEREBROVASCULAR ACCIDENT 43 0.0003
916 ABNORMAL BEHAVIOUR 10 0.0003
917 PRODUCT PRESCRIBING ERROR 6 0.0003
918 PRODUCT STORAGE ERROR 22 0.0003
919 NERVOUSNESS 13 0.0002
920 HIP FRACTURE 8 0.0002
921 LOCALISED INFECTION 6 0.0002
922 DRUG INEFFECTIVE 323 0.0002
923 ADVERSE DRUG REACTION 22 0.0002
924 IMPAIRED HEALING 8 0.0002
925 EYE SWELLING 9 0.0002
926 INJECTION SITE PAIN 74 0.0002
927 AGGRESSION 12 0.0002
928 SKIN DISCOLOURATION 11 0.0002
929 DERMATITIS 5 0.0002
930 EATING DISORDER 5 0.0002
931 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
932 SUICIDAL IDEATION 21 0.0002
933 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
934 APPLICATION SITE ERYTHEMA 6 0.0002
935 INJECTION SITE RASH 7 0.0002
936 CONVULSION 13 0.0002
937 GYNAECOMASTIA 7 0.0002
938 PRODUCT ADHESION ISSUE 8 0.0002
939 DISTURBANCE IN ATTENTION 12 0.0002
940 THROAT TIGHTNESS 6 0.0002
941 PSORIATIC ARTHROPATHY 9 0.0002
942 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
943 ANAPHYLACTIC REACTION 12 0.0002
944 PSORIASIS 28 0.0002
945 TOXICITY TO VARIOUS AGENTS 36 0.0002
946 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
947 UNEVALUABLE EVENT 16 0.0002
948 VISUAL ACUITY REDUCED 7 0.0002
949 SPEECH DISORDER 11 0.0002
950 DERMATITIS ATOPIC 11 0.0002
951 PRODUCT DOSE OMISSION ISSUE 61 0.0002
952 MENTAL DISORDER 9 0.0002
953 BREAST CANCER 19 0.0002
954 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
955 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
956 INJECTION SITE HAEMORRHAGE 16 0.0002
957 NEOPLASM MALIGNANT 13 0.0002
958 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
959 MOOD SWINGS 6 0.0002
960 HOSPITALISATION 28 0.0002
961 INCORRECT DOSE ADMINISTERED 41 0.0002
962 COLITIS ULCERATIVE 8 0.0002
963 THERAPY NON-RESPONDER 8 0.0002
964 PRODUCT QUALITY ISSUE 24 0.0002
965 EXTRA DOSE ADMINISTERED 7 0.0002
966 NEOPLASM PROGRESSION 6 0.0002
967 DRUG DOSE OMISSION 28 0.0002
968 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
969 CRYING 6 0.0002
970 AGITATION 12 0.0002
971 OVERDOSE 35 0.0002
972 DEATH 132 0.0002
973 SKIN IRRITATION 7 0.0002
974 DEVICE DIFFICULT TO USE 10 0.0002
975 ANGER 5 0.0001
976 MEDICATION ERROR 8 0.0001
977 WITHDRAWAL SYNDROME 6 0.0001
978 INJURY 10 0.0001
979 ADVERSE EVENT 13 0.0001
980 SKIN BURNING SENSATION 10 0.0001
981 TREATMENT FAILURE 11 0.0001
982 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
983 INJECTION SITE REACTION 9 0.0001
984 DEVICE MALFUNCTION 9 0.0001
985 DRUG WITHDRAWAL SYNDROME 11 0.0001
986 NO ADVERSE EVENT 22 0.0001
987 ACNE 8 0.0001
988 COMPLETED SUICIDE 8 0.0001
989 DEVICE ISSUE 7 0.0001
990 DRUG DOSE OMISSION BY DEVICE 6 0.0001